Text Size
30 studies found for:    " January 17, 2007":" February 16, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" January 17, 2007":" February 16, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva
Condition: HIV Infections
Interventions: Drug: Kaletra (lopinavir/ritonavir);   Drug: Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine)
2 Completed Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial
Condition: HIV Infections
Intervention: Behavioral: Nutritional
3 Completed Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users
Conditions: HIV Infections;   Substance Abuse;   Sexually Transmitted Diseases
Interventions: Behavioral: EDGE counseling, no maintenance;   Behavioral: EDGE counseling, plus maintenance;   Behavioral: Attention control
4 Unknown † Assessment of Asymptomatic Heart Disease in Children With HIV
Condition: HIV Infections
Intervention: Procedure: echocardiography and blood test
5 Completed Male Circumcision for HIV Prevention in Rakai, Uganda
Conditions: HIV Infections;   Herpesvirus 2, Human;   Syphilis;   Genital Diseases, Male
Intervention: Procedure: Adult male circumcision
6 Completed Long Term Treatment Interruptions
Conditions: HIV Infections;   AIDS
Interventions: Other: STI;   Drug: stable HAART
7 Completed Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults
Condition: HIV Infections
Interventions: Biological: EP-1233;   Biological: MVA-mBN32
8 Recruiting Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand
Condition: HIV Infections
Intervention:
9 Active, not recruiting Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men
Conditions: Anus Neoplasms;   HIV Infections
Intervention: Procedure: Argon Plasma Coagulation
10 Completed Effects of Anti-HIV Therapy on Nervous System Function
Condition: HIV Infections
Intervention:
11 Completed Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV
Condition: HIV Infections
Interventions: Drug: zidovudine;   Drug: amdoxovir;   Procedure: pharmacokinetic sampling
12 Terminated Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.
Conditions: HIV Infections;   Lymphoma, Non-Hodgkin
Intervention: Procedure: autologous peripheral blood cell transplantation
13 Unknown † SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
Conditions: HIV Infections;   Lipodystrophy
Interventions: Drug: atazanavir (Reyataz);   Drug: ritonavir (Norvir)
14 Completed Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals
Condition: HIV Infections
Interventions: Drug: Placebo;   Drug: Aprepitant
15 Terminated Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya
Condition: HIV Infections
Interventions: Drug: AZT/3TC/NVP (zidovudine/lamivudine/nevirapine);   Drug: d4T/3TC/NVP (stavudine/lamivudine/nevirapine);   Drug: AZT/3TC/ABC (zidovudine/lamivudine/abacavir);   Drug: d4T/3TC/ABC (stavudine/lamivudine/abacavir);   Drug: ddl/ABC/LPV/r (didanosine/abacavir/lopinavir-ritonavir);   Drug: AZT/3TC/ LPV/r (zidovudine/lamivudine/ lopinavir-ritonavir);   Drug: - ABC/ddI or TDF/NVP or EFV (abacavir/didanosine or tenofovir/nevirapine or efavirenz);   Drug: ABC/3TC/NVP (abacavir/lamivudine/nevirapine)
16 Terminated Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
Condition: HIV Infections
Interventions: Drug: AZT/3TC/NVP (zidovudine/lamivudine/nevirapine);   Drug: d4T/3TC/NVP (stavudine/lamivudine/nevirapine);   Drug: AZT/3TC/ABC (zidovudine/lamivudine/abacavir);   Drug: d4T/3TC/ABC (stavudine/lamivudine/abacavir);   Drug: ddI/ABC/LPV/r (didanosine/abacavir/lopinavir-ritonavir);   Drug: ABC/ ddI or TDF / NVP or EFV (abacavir / didanosine or tenofovir / nevirapine or efavirenz);   Drug: ABC/3TC/NVP (abacavir/lamivudine/nevirapine)
17 Unknown † A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor
Condition: HIV Infections
Intervention:
18 Completed Study of Pharmacokinetics in HIV-infected Women
Condition: HIV Infections
Intervention: Drug: antiretroviral treatment
19 Completed
Has Results 		Expanded Access Program for Maraviroc At Multiple Centers
Condition: Advanced HIV Infection
Intervention: Drug: maraviroc
20 Unknown † Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
Conditions: HIV Infections;   Tuberculous Meningitis
Intervention: Drug: Combivir and efavirenz
To Top

Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results
† Indicates status has not been verified in more than two years